Interestingly, an increase in PKM2 expression was observed in Luminal A tumours and a decrease of this gene expression was found in the Triple negative normal-like tumours, which are associated with better and worse outcomes, respectively [2], suggesting that PKM2 RNA levels can be used as cancer biomarker. This evidence concerns the gene PKM and cancer.